Johnson & Johnson Innovation - JJDC, Inc., 10% Owner at Protagonist Therapeutics, Inc (PTGX), bought 583,333 shares at $12.00 ($7.0M) on 2016-08-16, disclosed to the SEC on 2016-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| CVRX | SELL | 2024-03-06 | $96K | — | Filing → |
| CVRX | SELL | 2024-03-06 | $961 | — | Filing → |
| ACHN | SELL | 2017-11-22 | $101.0M | — | Filing → |